ABBV Stock — AbbVie Inc.

AbbVie Inc. (ABBV)

Updated October 16, 2026.

ABBV is a Stock. its distribution rate is 2.42%, its trailing-12-month yield is 2.42%. Dividend Vision Distribution Safety Score™ is 99/100 (Safe). Total return is 1311.4% over the past 13.8 years, 730.3 points ahead of SPY at 581.1%.

AbbVie is a research-based biopharmaceutical company that discovers, develops, manufactures, and sells medicines across immunology, oncology, neuroscience, and eye care, with major products including Skyrizi and Rinvoq for autoimmune and inflammatory diseases, Imbruvica and Venclexta for blood cancers, Botox for therapeutic and cosmetic uses, and treatments for conditions ranging from migraine to hepatitis C. The company pays quarterly distributions at a modest current distribution rate. AbbVie appeals to income-focused investors seeking exposure to the pharmaceutical sector.

ABBV performance versus SPY

Price and return data through 2026-10-16.

Total return is 1311.4% over the past 13.8 years, 730.3 points ahead of SPY at 581.1%. Over the past year its total return — price change plus distributions reinvested — is 29.6%. Its deepest 1-year drawdown was 15.7%.

ABBV key facts

Distribution Safety Score™

99 · Safe

Safety-Adjusted Yield

2.40%

Asset type

Stock

Asset class

Equity

Inception date

12/10/2012

Distribution rate

2.42%

Distribution frequency

Quarterly

Trailing yield

2.42%

5-year average yield

3.43

Last close

$285.42 (as of 2026-10-16)

Market cap

$504,370,615,485

Average volume

5774907.0

Dividend

$1.73

Ex-dividend date

10/15/2026

Payment date

11/16/2026

Beta

0.228

Payout ratio

63.7%

P/E ratio

80.63

Forward P/E

16.3934

EPS

$3.54

How Dividend Vision calculates yield and returns

Distribution rate (2.42%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (2.42%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ABBV risks and drawbacks

ABBV's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 15.7%.

Who may consider ABBV — and who may not

ABBV may suit someone looking for a high Distribution Safety Score, moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (ABBV pays quarterly); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

More on ABBV

• ETFs holding ABBV
• All tickers starting with A

Tagged: Dividend, Pharmaceutical.

Compare ABBV

ABBV vs similar funds:

• ABBV vs ABT
• ABBV vs JNJ

Frequently asked questions